ATTERX BIOTHERAPEUTICS
Atterx is developing fundamentally new therapeutics to combat the growing epidemic of antibiotic-resistant bacteria. Antibiotic resistance is a medical crisis, globally responsible for hundreds of thousands of deaths each year. ConjuGon's core technology is a new way to kill unwanted and even multi-drug resistant bacteria. The company is located in the MG&E Innovation Center in the University Research Park in Madison, Wisconsin.
ATTERX BIOTHERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2001-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.atterx.com
Total Employee:
1+
Status:
Active
Contact:
6084412891
Email Addresses:
[email protected]
Total Funding:
6.2 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Content Delivery Network COVID-19 Wix Wix Media
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
AkaRx
AkaRx develops therapeutics including the orally-available small molecule for use in the treatment of thrombocytopenia.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Current Employees Featured
Founder
Investors List
Michigan Rise
Michigan Rise investment in Series C - Atterx Biotherapeutics
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Venture Round - Atterx Biotherapeutics
Rosetta Partners
Rosetta Partners investment in Venture Round - Atterx Biotherapeutics
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Venture Round - Atterx Biotherapeutics
Official Site Inspections
http://www.atterx.com Semrush global rank: 8.98 M Semrush visits lastest month: 445
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Atterx Biotherapeutics"
About | Atterx Biotherapeutics
About Atterx Antibiotics are among the most commonly prescribed drugs, and have saved millions of lives since they were introduced to patients many decades ago. However, they are …See details»
Atterx BioTherapeutics, Inc. - LinkedIn
Atterx BioTherapeutics, Inc. | 40 followers on LinkedIn. Proprietary products for the prevention and treatment of multi-drug resistant Gram negative bacterial infections.See details»
Atterx Biotherapeutics 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for Atterx Biotherapeutics. Use the PitchBook Platform to explore the full profile.See details»
Atterx Biotherapeutics - Crunchbase Company Profile …
Atterx is developing fundamentally new therapeutics to combat the growing epidemic of antibiotic-resistant bacteria. Antibiotic resistance is a medical …See details»
Atterx Biotherapeutics, Inc. Company Profile | Madison, WI ...
Find company research, competitor information, contact details & financial data for Atterx Biotherapeutics, Inc. of Madison, WI. Get the latest business insights from Dun & Bradstreet.See details»
Atterx Biotherapeutics - Overview, News & Similar companies
View Atterx Biotherapeutics (www.atterx.com) location in Wisconsin, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Atterx BioTherapeutics Company Profile - Craft
Atterx BioTherapeutics is a company developing products that prevent and treat antibiotic-resistant bacterial infections. It offers C-1205, a drug that utilizes bacterial interference …See details»
Atterx Biotherapeutics Company Profile | Management and
Find contact information for Atterx Biotherapeutics. Learn about their Research & Development, Business Services market share, competitors, and Atterx Biotherapeutics's email format.See details»
Atterx - Solutions to treat drug resistant pathogens
May 1, 2025 Atterx is developing novel products that prevent and treat antibiotic-resistant bacterial infections. Antibiotics and have saved millions of lives since they were introduced decades ago. Bacteria that were once easy to …See details»
Atterx Biotherapeutics - 2025 Company Profile - Tracxn
May 28, 2025 Atterx Biotherapeutics is a series A company based in Madison (United States), founded in 2001. It operates as a Therapeutics to fight multi-drug resistant bacterial infections. …See details»
Atterx Biotherapeutics Company Profile -Sales, Contacts, …
Atterx Biotherapeutics is located in Madison, Wisconsin. This organization primarily operates in the Biotechnical Research, Commercial business / industry within the Engineering, …See details»
Leadership | Atterx Biotherapeutics
Previous to joining Atterx, he held senior management positions as Director of Cell Biology & Transgenesis at Infigen, Inc. and as Director of Government Programs at OpGen, Inc.See details»
Atterx Biotherapeutics - Financial Details - Crunchbase
Atterx develops therapeutics to fight the growing epidemic of antibiotic resistant bacteria.See details»
Atterx BioTherapeutics, Inc. Overview - SignalHire
Organization Website atterx.com Atterx BioTherapeuti... industries Pharma Headquarters Location 505 S ROSA RD, Madison, Wisconsin, 53719 USSee details»
atterx.com
Atterx.comSee details»
Leadership | Atterx Biotherapeutics
Mr. Evans, of Rosetta Partners, a biotechnology investment firm, has raised the majority of equity funding for Atterx over the last eight years. He has been active as an investor in hedge funds …See details»
Chief Executive Officer - Atterx Biotherapeutics - LinkedIn
Chief Executive Officer at Atterx Biotherapeutics · Experience: Atterx Biotherapeutics · Location: Madison · 57 connections on LinkedIn. View Steve Watt’s profile on LinkedIn, a professional ...See details»
Startup Spotlight: Atterx - 20Fathoms
Mar 13, 2025 Jim Millar, CEO at Atterx, connected with 20Fathoms to share more about his experience leading a startup within Traverse City’s entrepreneurial ecosystem.See details»
The Problem | Atterx Biotherapeutics
Atterx is developing novel products that prevent and treat antibiotic-resistant bacterial infections. Antibiotics are among the most commonly prescribed drugs, and have saved millions of lives …See details»
Blog | Atterx
May 3, 2023 Atterx Biotherapeutics Receives FDA Fast Track Designation forC-1205 for the Prevention of Catheter Associated Urinary Tract Infections (CAUTI) “We are very pleased to …See details»